Skip to main content
EcoSphere News
PoliticsSouth Africa

McKinsey Faces $122 Million Fine in South Africa Bribery Scandal

The consulting firm settles charges related to bribery for government contracts, with a former senior partner pleading guilty in the case.

By Michael Forsythe and Walt BogdanichSource: nytimes.com1 min read
McKinsey Faces $122 Million Fine in South Africa Bribery Scandal
Image via nytimes.com

In brief

McKinsey & Co. has agreed to pay over $122 million to resolve a felony bribery case linked to its operations in South Africa, highlighting ongoing legal issues the firm faces in connection to alleged unethical practices and prior opioid-related settlements.

In a significant legal development, McKinsey & Co. has entered a deferred prosecution agreement resulting in a $122 million fine related to a bribery investigation tied to its South African operations. Federal prosecutors in New York announced the agreement, citing that it would dismiss the bribery charge if McKinsey complies with specific conditions over the next three years. Furthermore, Vikas Sagar, a former senior partner from McKinsey’s Johannesburg office, has pleaded guilty to conspiring to breach anti-corruption laws, bringing further scrutiny to the firm.The investigation revolved around McKinsey’s dealings with two South African state-owned enterprises, involving a longtime arrangement where consulting contracts worth millions were granted under suspicious circumstances. Prosecutors revealed that Sagar had illicitly obtained confidential information, enabling McKinsey to generate $85 million in profits from contracts, some of which were funneled as bribes to government officials.This inquiry follows a string of controversies for McKinsey, previously highlighted in a 2018 New York Times investigation, which characterized its actions in South Africa as potentially the firm’s gravest misstep in a century of operation. Additionally, amidst the ongoing crisis of opioid addiction in the U.S., McKinsey has recently faced over $1 billion in settlements for its role in advising pharmaceutical companies like Purdue Pharma. This ongoing scrutiny of its practices continues to raise questions about ethical governance within major consulting firms.

Topics

More on this story